Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Toprol-XL Generic Approved By FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Sandoz' 25 mg generic version of metoprolol succinate extended release was approved July 31.

You may also be interested in...



AstraZeneca Releases Toprol-XL “Authorized” Generic Following Sandoz Launch

25 mg dosage strength accounts for 20% of Toprol-XL sales.

AstraZeneca Releases Toprol-XL “Authorized” Generic Following Sandoz Launch

25 mg dosage strength accounts for 20% of Toprol-XL sales.

KV Petitions FDA To Retain 180-Day Exclusivity For Generic Toprol-XL Doses

FDA has already issued tentative approval to Sandoz for the two doses.

Related Content

Topics

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel